This exchange-traded fund (ETF) primarily allocates its capital to common equity securities issued by companies globally, irrespective of their market capitalization. Its central investment theme revolves around enterprises driving the "biology revolution," whether they are classified as growth-oriented, value-based, or a blend of both. Periodically, the fund may dedicate a substantial segment of its assets to firms operating within one or more interconnected industries or sectors.